Prescription Required
Inclusive of all taxes
In Osteoporosis Osteoporosis is a common condition that causes bones to become fragile and brittle so that they break (fracture) more easily. Fractures may be painful and restrict a person’s ability to carry out their normal daily tasks. Risofos 35mg/250mg/400IU Kit reduces the risk of a fracture occurring in osteoporosis. It also helps in the growth and development of bones as well as maintain strong bones. Along with medicines, eat a balanced diet rich in calcium and vitamin D like dairy products, green leafy vegetables etc.
It is unsafe to consume alcohol with Risofos 35mg/250mg/400IU Kit.
Risofos 35mg/250mg/400IU Kit may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Risofos 35mg/250mg/400IU Kit is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Risofos 35mg/250mg/400IU Kit does not usually affect your ability to drive.
Risofos 35mg/250mg/400IU Kit is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Risofos 35mg/250mg/400IU Kit may not be needed in these patients. Please consult your doctor.
Risofos 35mg/250mg/400IU Kit is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Risofos 35mg/250mg/400IU Kit may not be needed in these patients. Please consult your doctor.
If you miss a dose of Risofos 35mg/250mg/400IU Kit, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More